Accolade

Accolade, Inc. engages in the provision of personalized health and benefits solutions. Its products include Accolade Total Benefits, which is designed for employers with low employee adoption of healthcare and benefits programs, Accolade Total Care, which focuses on influencing the actual interactions between employees and providers, and are also interested in care management services, and Accolade Total Health and Benefits, which offers a full suite of solutions. The company was founded by Thomas K. Spann, J. Michael Cline, and Sudhir Steven Singh in 2007 and is headquartered in Seattle, WA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Accolade reports strong Q4 performance, faces market challenges ahead

Accolade's transformation into a personalized healthcare company has shown strong growth and improved financial performance. The company faces challenges related to operational excellence, market strategy, and the impact of industry decisions. However, opportunities lie in leveraging technology for healthcare and the upcoming Capital Markets Day to showcase growth prospects.

Accolade exceeds Q3 revenue guidance, eyes profitability by fiscal '25

Accolade's Q3 earnings call highlighted strong performance, diverse customer relationships, and growth opportunities in government business and virtual care. The company aims to achieve profitability by fiscal '25 through strategic investments and operational improvements, leveraging its competitive advantage in delivering ROI and performance guarantees.

Accolade reports robust Q4 performance, eyes tech-driven growth opportunities

Accolade's Q4 2023 Earnings Call highlighted strong financial performance, customer focus, and strategic initiatives. The company faces challenges in timing performance guarantees but sees opportunities in technology adoption and growth strategies.

Accolade surpasses Q1 expectations, eyes growth in healthcare partnerships

Accolade's Q1 performance exceeded expectations, with a focus on growth drivers and streamlining decision-making. Despite challenges in the government business, the company is optimistic about future growth opportunities and customer acquisition. Improved guidance and a strong pipeline indicate a positive outlook for the year.

Accolade beats Q2 revenue targets, eyes profitability in fiscal '25

Accolade exceeded revenue and EBITDA expectations in Q2, driven by strong customer additions and unique service offerings. Despite challenges from drug impacts and contract disputes, the company maintains its full-year guidance and eyes profitability in fiscal '25.

Accolade excels in Q3, eyes automation for growth opportunities

Accolade's Q3 performance exceeded expectations, with a positive outlook for future revenue and EBITDA. Differentiation in services and technology integration drive operational excellence. Uncertainty around TRICARE contract and focus on automation and growth opportunities.

Accolade reports robust Q4 earnings, eyes sustainable growth in '25

Accolade's strong performance in Q4 2024 sets a positive trajectory for fiscal year '25, with a focus on sustainable growth and profitability. The company's strategic strengths in serving a large customer base, successful partnerships, and innovative offerings position it well for future opportunities despite challenges in meeting revenue guidance and addressing post-security breach concerns.

Accolade reports strong Q2 earnings, focuses on profitability and growth

Accolade's Q2 performance exceeded expectations, emphasizing profitability and member experience.
The company's strengths lie in revenue growth, cost management, and competitive wins.
Challenges include cost structure management and balancing growth with profitability.
Opportunities exist in enhancing member experience, expanding partnerships, and driving sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company was founded by Thomas K. Spann and J. Michael Cline in January 2007 and is headquartered in Seattle, WA.

SEATTLE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Credit Suisse 30th Annual Healthcare Conference, including a fireside chat presentation on Thursday, November 11, 2021 at 12:10 p.m. E.T. A webcast and related presentation materials will be available at ir.accolade.com.

Accolade to Participate in the Credit Suisse 30th Annual Healthcare Conference

Accolade has seen continued growth this year.

Accolade: I May Add To My Position

SEATTLE, Oct. 14, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), a healthcare provider that serves over 400 employers and millions of members, will be at HLTH Boston 2021 to engage in discussions about how companies can improve care, clinical outcomes, and lower costs. Please join us for the following experiences: "The New Shape of Work" panel discussion on Monday, October 18th at 2:50 P.M.

Accolade to Showcase Personalized Healthcare for Employers and Health Plans at HLTH Boston 2021

SEATTLE, Oct. 12, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), a healthcare provider serving millions of people and their families, announced today that WellRight, the provider of the nation's most holistic and comprehensive corporate well-being platform, has joined the company's trusted partner ecosystem. Accolade uses a rigorous methodology to select healthcare partners who are change agents in their respective categories and deliver clinically compelling solutions that combine exceptional health outcomes, service, and experience.

Accolade Brings WellRight's Corporate Wellness Programs into its partner ecosystem

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q2 2022 Results - Earnings Call Transcript

SEATTLE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2021.

Accolade Announces Results for Fiscal Second Quarter 2022

DALLAS, Oct. 4, 2021 /PRNewswire/ -- Insurance Applications Group, Inc. (IAG), a leading Insurtech company specializing in proprietary employee benefit products and administrative technologies for the hotel, restaurant, temporary employment, and other high-turnover industries today announced the launch of HospitalityCARE VPC (Virtual Primary Care), an employer-paid health care service and insurance bundle that couples PlushCare, the leading primary care telemedicine platform, with medical and dental insurance benefits for the hospitality industry. HospitalityCARE VPC is designed for companies seeking to recruit and retain new employees amid the current, unprecedented labor shortage.

Insurtech Leader Announces New Employer-Paid Insurance Plan Featuring Virtual Primary Health Care, Dental Coverage and Investing Platform Connectivity for Hospitality Sector Employees

Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Accolade (ACCD) Q2 Earnings Expected to Decline

Health benefits platform company Accolade is expanding its offerings to add two personalized services with an emphasis on mental health, the company announced Tuesday.

Accolade doubles down on personalized mental health services with new offerings

SEATTLE, Sept. 21, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with exceptional healthcare, today introduced Personalized Healthcare, a new category that enables a nationally scalable model of value-based care to meet the quadruple aim.

Accolade introduces new healthcare category: Personalized Healthcare

SEATTLE, Sept. 20, 2021 /PRNewswire/ -- WHAT:             Accolade, Inc. (Nasdaq: ACCD) the company that provides millions of people and their families with exceptional healthcare will be making an announcement during the opening keynotes Evolve21, the company's annual customer event being held virtually from September 21-23, 2021.

Accolade Invites Media, Investors and General Public to Opening of Evolve21

Accolade Inc (NASDAQ:ACCD) is up 0.7% at $45.31 this morning, after Baird upgraded the healthcare technology name to "outperform" from "neutral.

Accolade Stock Inches Higher After Baird Upgrade

SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences:

Accolade to Participate in Upcoming Investor Conferences

SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021 at 11:00 a.m. E.T. An audio webcast and related presentation materials will be available at ir.accolade.com.

Accolade to Participate in the 41st Annual Canaccord Genuity Growth Conference

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q1 2022 Results - Earnings Call Transcript

SEATTLE, July 08, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced financial results for the fiscal first quarter ended May 31, 2021.

Accolade Announces Results for Fiscal First Quarter 2022

SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal first quarter 2022 financial results on Thursday, July 8, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Accolade to Announce Fiscal First Quarter 2022 Financial Results

SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced it has completed the acquisition of PlushCare, a leading provider of virtual primary care and mental health treatment. Together with its expert medical opinion capability, Accolade's personalized service will deliver collaborative, comprehensive and holistic care options for the workforces of corporate payers.

Accolade Completes Acquisition of PlushCare

Malibu Boats

MKS Instruments

TTEC Holdings

Williams-Sonoma

The Dow Jones rose 40 points, while both the S&P 500 and Nasdaq traded flat. Make the most of this market with today's top buys from Q.ai's artificial intelligence.

Acco Brands Corp And Malibu Boats Inc Among Today's Top Buys

American Well Corporation

GoodRx Holdings

Teladoc

SOC Telemed

To make the most of the booming telehealth industry, players are coming up with IPOs and resorting to mergers and acquisitions.

Booming Telehealth Market Lures More IPOs and M&A Deals

SEATTLE, June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcare, today announced a series of changes to its board of directors that will bolster the board with significant healthcare and human resources expertise. Incoming board member Elizabeth ("Betsy") Nabel, M.D.

Betsy Nabel and Jeff Brodsky join Accolade Board of Directors

Accolade, Inc. (ACCD) CEO Rajeev Singh on Q4 2021 Results - Earnings Call Transcript

SEATTLE, May 05, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Accolade, Inc. (NASDAQ: ACCD) please note that the entire Consolidated Statements of Operations (unaudited) table has been replaced. The corrected release follows:

CORRECTION -- Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021

SEATTLE, May 05, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced financial results for the fiscal fourth quarter and full year ended February 28, 2021.

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2021

The news: Seattle-based health benefits platform Accolade will pay up to $450 million to acquire PlushCare, a Bay Area-based startup that offers virtual primary care.

News for Accolade Stock (ACCD)